Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia
Clinical trial NCT00017589 · COMPLETED
Trial details
- NCT number
- NCT00017589
- Sponsor
- Genta Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-12-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.